Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of Bevacizumab and Weekly Docetaxel in Elderly (greater than or equal to 75 Years) Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).

Trial Profile

Evaluation of Bevacizumab and Weekly Docetaxel in Elderly (greater than or equal to 75 Years) Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Dec 2017

At a glance

  • Drugs Bevacizumab; Docetaxel
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 05 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 14 Aug 2012 Planned End Date changed from 1 Feb 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov (NCT01665443).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top